PULOCIMAB
UNII FDL8DA4XV4

Substance Identification & Data

This profile provides standardized clinical and technical data for Pulocimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) FDL8DA4XV4.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2428381-49-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

FDL8DA4XV4

CAS Registry Number

2428381-49-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

PULOCIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C182005

National Cancer Institute reference terminology for clinical and research data.

INN ID

11807

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Pulocimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PULOCIMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2) (HUMAN MONOCLONAL AK109 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL AK109 .KAPPA.-CHAIN, DIMER

PULOCIMAB [INN]

PULOCIMAB [WHO-DD]